Cargando…
Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, leading to significant morbidity and mortality. The objective of this work is to describe a series...
Autores principales: | Siddiqui, Mahwash, Vora, Amy, Ali, Sadia, Abramowitz, Jessica, Mirfakhraee, Sasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692539/ https://www.ncbi.nlm.nih.gov/pubmed/33294765 http://dx.doi.org/10.1210/jendso/bvaa171 |
Ejemplares similares
-
SAT-117 Refractory Paraneoplastic Non Islet Cell Tumor Hypoglycemia (NICTH) from Hepatocellular Carcinoma Managed with Somatostatin Analogue and Glucocorticoids
por: Siddiqui, Mahwash Fatima, et al.
Publicado: (2020) -
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature
por: Oziel-Taieb, Sandrine, et al.
Publicado: (2022) -
SUN-319 Failure Of Pasireotide To Control Hypoglycemia In A Men-1 Patient With Metastatic Insulinoma
por: de Almeida, Tobias, et al.
Publicado: (2019) -
Insulinoma or non-insulinoma pancreatogenous hypoglycemia? A diagnostic dilemma
por: Anderson, Blaire, et al.
Publicado: (2016) -
Non-Islet Cell Tumor Hypoglycemia: A Rare Cause of Hypoglycemia in Pulmonary Sarcomatoid Cancer
por: Legare, Timothy B, et al.
Publicado: (2017)